drugset / Trial / NCT00671268
Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
Efficacy and Safety from a high-dosed subcutaneous recombinant preparation
Timeline
- Start
- 2008-03
- Primary completion
- 2012-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AL0704rP | Protein / enzyme biologic | — | Subcutaneous |